Regulation of Ubiquitination and Arthritis
Regulation of Ubiquitination and Arthritis
批准号:
10399464
负责人:
AVERIL I MA
金额:
$40.38万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-05 至 2024-04-30
关键词:
AblationAgeAntibodiesArthritisAutoimmunityBindingBiochemicalCellsChronicComplementComplexCysteineDataDendritic CellsDevelopmentDiseaseDissectionEpigenetic ProcessExperimental ModelsFunctional disorderFutureGenetic EpistasisGoalsHomeostasisHumanHuman GeneticsImmuneImmune responseImmune signalingImmunologicsIn VitroInflammasomeInflammatoryInflammatory ArthritisInterleukin-1Interleukin-17JointsKnock-inKnock-in MouseKnockout MiceLeadLigandsLigaseLinkMediatingMolecularMouse StrainsMusMutant Strains MiceMutationPainPathway interactionsPatientsPenetrancePersonsPhenotypePhysiologicalPoint MutationPredispositionProteinsPsoriatic ArthritisRIPK1 geneRegulationRheumatismRheumatoid ArthritisRoleSeriesSignal PathwaySignal TransductionSpondylarthritisStudy modelsSyndromeTNF geneTNFSF11 geneTRAF6 geneTestingTherapeuticTumor Necrosis Factor ReceptorUBD proteinUbiquitinUbiquitinationZinc Fingersbasedisabilityexperimental studygenetic variantimproved outcomein vivoinsightjoint injurymacrophagemouse modelneutrophilnovel therapeuticspreservationpreventrecruitresponseubiquitin-protein ligase
中文摘要
项目摘要/摘要
关节炎是一种慢性、进行性全身性炎症性疾病,会导致严重的关节损伤、疼痛、
功能障碍和残疾。A20,也被称为TNFAIP3,在基因和表观遗传上与人类有关联
关节炎,以及最近的实验研究表明A20参与了几种潜在的病理生理调节
关节炎的路径。携带A20缺陷树突状细胞或A20缺陷巨噬细胞/中性粒细胞的小鼠
自发性地患上关节炎。A20可限制多种炎症途径,包括TLR、肿瘤坏死因子α和
发炎的信号。A20是如何发挥这些关键功能并预防关节炎的,目前还知之甚少。
A20具有多个基序,介导脱泛素、泛素结合和E3泛素连接酶活性。这个
这项建议的目标是了解A20预防关节炎的生化机制。我们有
产生了几个带有策略性点突变的小鼠敲入系,这些突变消除了特定的生化
A20的功能。使用这些新的小鼠品系,我们将确定A20‘S泛素依赖于哪一个
这些功能保护了预防关节炎的细胞和分子途径。拟议的研究将
基于人类关节炎易感蛋白建立一种新的健壮的自发性关节炎小鼠模型。
英文摘要
Project Summary/Abstract
Arthritides are chronic, progressive systemic inflammatory diseases that lead to significant joint damage, pain,
dysfunction, and disability. A20, also known as TNFAIP3, is genetically and epigenetically linked to human
arthritis, and recent experimental studies implicate A20 in regulating several potential pathophysiological
arthritis pathways. Mice bearing A20 deficient dendritic cells or A20 deficient macrophages/neutrophils
spontaneously develop arthritis. A20 restricts several inflammatory pathways, including TLR, TNFα, and
inflammasome signals. How A20 performs these critical functions and prevents arthritis are poorly understood.
A20 has multiple motifs that mediate deubiquitinating, ubiquitin binding, and E3 ubiqutin ligase activities. The
goal of this proposal is to understand the biochemical mechanisms by which A20 prevents arthritis. We have
generated several knock-in lines of mice with strategic point mutations that abrogate specific biochemical
functions of A20. Using these new mouse strains, we will determine which of A20's ubiquitin dependent
functions preserve the cellular and molecular pathways that prevent arthritis. The proposed studies will
establish a new robust mouse model of spontaneous arthritis based on a human arthritis susceptibility protein.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/bs.ai.2020.10.001
发表时间:
2020-10
期刊:
Advances in immunology
影响因子:
--
作者:
[Bahram Razani;B. Malynn;A. Ma]
通讯作者:
Bahram Razani;B. Malynn;A. Ma
Ubiquitination, Intestinal Homeostasis and Cancer
-
批准号:10522777
-
项目类别:
-
资助金额:$44.86万
-
财政年份:2022
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitination, Intestinal Homeostasis and Cancer
-
批准号:10685627
-
项目类别:
-
资助金额:$43.96万
-
财政年份:2022
-
负责人:AVERIL I MA
-
依托单位:
Regulation of Ubiquitination and Arthritis
-
批准号:9919373
-
项目类别:
-
资助金额:$40.33万
-
财政年份:2018
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8638002
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8829675
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8321633
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8436190
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:8363762
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:8169756
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2010
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:8007517
-
项目类别:
-
资助金额:$9.86万
-
财政年份:2010
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7957395
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2009
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7724203
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2008
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7601849
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7369092
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2006
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7484193
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7493167
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7117352
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:6957143
-
项目类别:
-
资助金额:$42.07万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7920534
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7265100
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: